Anticoagulation

Elisabetta Bigagli, Jacopo Angelini, Alessandro Mugelli, et al

Read time: 18m 58s

Ton Duy Mai, Tri Huynh Quang Ho, Sy Van Hoang, et al

Read time: 19m 6s
SCAI 25: Insights from the TRITAVI Registry

Francesco Pelliccia

Watch time: 11m 23s

Bianca Rocca, Hugo ten Cate

Read time: 17m 22s
ACC 25: Optimizing DAPT Duration

Hyo-Soo Kim

Watch time: 9m 39s
ACC 25: The SMART-CHOICE 3 Trial

Joo-Yong Hahn

Watch time: 4m 14s
ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s
ACC 25: The Phase 3 REVERSE-IT Trial

Deepak L Bhatt

Watch time: 4m 15s

Monika Bhandari, Akshyaya Pradhan, Pravesh Vishwakarma, et al

Read time: 27m 35s
AHA 24: The OPTION Trial

Oussama M Wazni

Watch time: 5m 15s
TCT 24: The PEERLESS Trial

Dr Wissam A Jaber

Watch time: 6m 16s

Mario DiazNuila-Alcazar, Daniel Valcárcel-Paz, Pablo Del Castillo-Vásquez, et al

Read time: 5m

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Broadcast

Anticoagulation

Guidelines & Statements
What’s New in the European ACS Guidelines and How Will My Practice Change?

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Kerry Layne, Albert Ferro

Julia Sikorska, James Uprichard

Mario Petretta, Pierluigi Costanzo, Alberto Cuocolo

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Yugo Yamashita

Frédéric Michard

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan

Watch time: 17m 13s

Media

Could Acute COVID-19 Infection Ignite Thrombotic Risk?

Naveed Sattar, Philippe Gabriel Steg, Lale Tokgözoğlu, et al

Watch time: 35m 13s (4 videos)

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Tratamiento con ACOD en pacientes con FA post-ICP

Pablo Avanzas, Román Freixa Pamias, Antoni Martínez-Rubio, et al

Watch time: 28m 4s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Emerging Clinical Evidence on Left Atrial Appendage Closure: A Case-based…

Ignacio Cruz, Jens Erik Nielsen Kudsk, Prof Henning Ebelt, et al

Watch time: 2h 5m 51s
TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag,

Watch time: 17m 13s
ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall

Watch time: 15m 2s
EuroPCR 2021: Findings From the POEM Study

Giulio G Stefanini

Watch time: 8m 8s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas

Watch time: 6m 33s
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao

Watch time: 8m 40s
STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe

Watch time: 5m 43s
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas

Watch time: 9m

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

Watch time: 6h 2m 18s (6 videos)

Articles

Approach to Anticoagulation Therapy in Patients with Combined Atrial Fibrillation and Coronary Artery Stents: A Review of the Literature

Ben Borokhovsky

,

Perry J Weinstock

,

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e21.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO4
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 847
  • Downloads: Downloads 98
  • Read time: 18m

Anticoagulant Therapy in Coronary Artery Disease

Maki Komiyama

,

Gheorghe-Andrei Dan

,

Koji Hasegawa

,

Published:

18 April 2023

Citation:

European Cardiology Review 2023;18:e14.

DOI:

https://doi.org/10.15420/ecr.2022.66
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2607
  • Downloads: Downloads 138
  • Read time: 4 Mins

Role of Newer Oral Anticoagulants for Post-operative Prophylaxis

Han Naung Tun

,

May Thu Kyaw

,

Erik Rafflenbeul

,

Xiuhtlaulli López Suástegui

,

Published:

13 May 2022

Citation:

European Cardiology Review 2022;17:e11.

DOI:

https://doi.org/10.15420/ecr.2021.55
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5498
  • Downloads: Downloads 369
  • Citations: 9
  • Read time: 20m 11s

European Society of Cardiology Highlights: Late-breaking Trials – COVID-19

Maki Komiyama

,

Koji Hasegawa

,

Published:

17 February 2022

Citation:

European Cardiology Review 2022;17:e04.

DOI:

https://doi.org/10.15420/ecr.2022.03
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 809
  • Downloads: Downloads 40